window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : August 19, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

FDA Approval

  • Clinical & Regulatory,Drug Delivery & Formulation,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    FDA grants Priority Review to Belite Bio’s tinlarebant for Stargardt disease

    The FDA has accepted Belite Bio’s application for tinlarebant and [...]

    August 13, 2026
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas

    FDA approves Moderna’s mRNA flu vaccine mFLUSIVA

    The FDA has approved Moderna’s mRNA seasonal influenza vaccine mFLUSIVA [...]

    August 13, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics

    FDA issues Complete Response Letter for ITM-11 over manufacturing issues

    The FDA has issued a Complete Response Letter for ITM-11, [...]

    August 11, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Pharmaceuticals and therapeutics

    FDA approves Meitheal’s rapid-acting insulin biosimilar Garzulys

    The US Food and Drug Administration (FDA) has approved Meitheal [...]

    July 31, 2026
  • Clinical & Regulatory,Medical devices,Pharmaceuticals and therapeutics,Research & Development

    Tenpoint submits UK application for presbyopia eye drop YUVEZZI

    Tenpoint Therapeutics has submitted a Marketing Authorization Application (MAA) to [...]

    July 14, 2026
  • Biotech & Pharma Business

    Rigel completes VEPPANU licensing deal with Arvinas and Pfizer

    Rigel Pharmaceuticals has completed its previously announced licensing agreement with [...]

    June 17, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Digital & Data,Medical devices,Therapeutic Areas

    Mental health systems strain as demand and funding shifts drive push for multimodal care

    Mental health systems in the US and UK have entered [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas

    Milestone launches CARDAMYST nasal spray for PSVT in the United States

    Milestone Pharmaceuticals has announced the commercial availability of CARDAMYST (etripamil) [...]

    May 5, 2026
  • Advanced Therapies,Pharmaceuticals and therapeutics,Therapeutic Areas

    Grifols fibrinogen concentrate FESILTY approved in the US for acute bleeding in congenital fibrinogen deficiency

    Grifols has received US Food and Drug Administration (FDA) approval [...]

    May 5, 2026
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas

    Grifols secures expanded FDA label for Thrombate to include pediatric hereditary antithrombin deficiency

    Grifols has received US FDA approval for an expanded indication [...]

    May 5, 2026
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Prescient integrates Uptake and Dolon to create 550-strong pharma consultancy
    Categories: Biotech & Pharma Business
  • Tris Pharma partners with Calm Health and ADHD Central to support patients
    Categories: Digital & Data, Pharmaceuticals and therapeutics, Therapeutic Areas
  • US FDA inspects Aurisco site for generic oligonucleotide manufacturing
    Categories: Drug Discovery & Development, Manufacturing & Supply Chain, Pharmaceuticals and therapeutics, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top